Alpha-fetoprotein (AFP) Testing Market - Forecast(2021 - 2026)

Report Code: HCR 0109 Report Format: PDF + Excel (Delivery in 48 Hrs)

Alpha-Fetoprotein (AFP) Testing Market Report Overview

Alpha-fetoprotein (AFP) Testing Market size in 2019 is estimated to be $5,195million, growing at a CAGR of 5.5% during the forecast period 2020-2025. An alpha-fetoprotein (AFP) test is a blood test that measures the amount of AFP present in blood. It’s usually part of what’s called a triple screen or quad screen in the second trimester of pregnancy. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. AFP tests are commercially available and widely used for testing various cancer related test. Increasing cancer cases and technological advancement are the major factors driving the growth of the market. Moreover, rising disposable income and advancement of R&D activities further enhance the overall market demand for alpha-fetoprotein testing during the forecast period 2020-2025.

Alpha-Fetoprotein (AFP) Testing Market Report Coverage

The report: “Alpha-fetoprotein (AFP) Testing Market – Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Alpha-fetoprotein (AFP) Testing Market:
By Cancer Type : Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others
By End Use Industry : Hospitals, Clinics, Others
By Geography: North America, Europe, Asia-Pacific, and Rest of the World

Key Takeaways

  • In 2019, North America dominates the Alpha-fetoprotein (AFP) Testing Market owing to increasing incidence of chronic disease and increasing investment for cancer research.
  • Increasing cancer cases and technological advancement is driving the market growth of alpha-fetoprotein testing.
  • Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Alpha-fetoprotein (AFP) Testing Market report.
  • False positive results or false negative results in testing are challenging the growth of the market. 

Alpha-Fetoprotein (AFP) Testing Market Cancer Segment Analysis - By Type 

Based on the Cancer Type , Alpha-fetoprotein (AFP) Testing Market is segmented into Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others. The liver cancer segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 4.8% during the forecast period 2020-2025.  According to World Health Organization, about 8 million people are diagnosed with this cancer which is also a leading cause of cancer deaths are contributing to the growth of this segment.

Alpha-Fetoprotein (AFP) Testing Market Cancer Segment Analysis - By End-Use Industry

Based on the End Use Industry, Alpha-fetoprotein (AFP) Testing Market is segmented into Hospitals, Clinics, Others. In 2019, hospitals held the largest share in the Alpha-fetoprotein (AFP) Treatment Market. This is mainly owing to availability of proper technology for treatment, skilled professional which are contributing to the growth of this segment.


Alpha-Fetoprotein (AFP) Testing Market Cancer Segment Analysis - By Geography

North America dominated the Market share accounting for 45% of the market in 2019. This is mainly owing to increasing incidence of chronic disease and increasing investment for cancer research. According to National Cancer Institute about 1 million cases of cancer are diagnosed in the U.S. which are contributing the growth of this segment.
However, the Asia Pacific region is projected to be the fastest-growing during the forecast period 2020-2025. This is owing to increasing disposable income and increasing healthcare expenditure.

Alpha-Fetoprotein (AFP) Testing Market Drivers

Increasing Cancer Cases

Increasing cancer cases and rising chronic disease are some factors driving the market growth of this segment. According to World Health Organization, about 18 million people are suffering from cancer which are increasing the market growth of alpha-fetoprotein testing.

Technological Advancement 

Increasing technological advancement and rising research in medical are some factor driving the growth of the market. Moreover, increasing research and development activities helps to develop new treatments for multiple diseases are contributing to the growth of Alpha-fetoprotein (AFP) Testing Market.

Alpha-Fetoprotein (AFP) Testing Market Challenges 

Lack of skilled professional and false positive results or false negative results in testing are challenging the growth of the market. Moreover, lack of awareness among are further restraining its market growth during the forecast period 2020-2025.

Alpha-Fetoprotein (AFP) Testing Industry Outlook

Product launches, Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Alpha-fetoprotein (AFP) Testing Market. Alpha-fetoprotein (AFP) Testing top 10 companies are Biomedical Diagnostics, Abbott Laboratories, Bio-Rad Laboratories, Kreatech Diagnostics, Beckman Coulter, and Roche Diagnostics, Thermo Fisher Scientific, Dickinson and Company, Geno Technology GeneCopoeia, Inc and Sartorius.

Acquisitions/Product Launches:

  • On 2 January 2017, Dickinson and Company has acquisition with Becton for the development in healthcare sector.
  • On 7 March 2019, Biomedical Diagnostics Inc. are developing women’s reproductive health issues.


1. Alpha-fetoprotein (AFP) Testing Market Overview
    1.1 Definitions and Scope
2. Alpha-fetoprotein (AFP) Testing Market Executive Summary
    2.1 Market Size and Key Trends 
    2.2 Key trends by Cancer Type
    2.3 Key trends by End-Use Industry
    2.4 Key trends by Geography
3. Alpha-fetoprotein (AFP) Testing Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis 
    3.5 Pricing Analysis
4. Alpha-fetoprotein (AFP) Testing Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Alpha-fetoprotein (AFP) Testing Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Alpha-fetoprotein (AFP) Testing Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes 
7. Alpha-fetoprotein (AFP) Testing Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Alpha-fetoprotein (AFP) Testing Market– By Cancer Type (Market Size -$Million/$Billion)
    8.1 Liver Cancer
    8.2 Testes Cancer
    8.3 Ovarian Cancer
    8.4 Biliary Tract Cancer
    8.5 Stomach Cancer
    8.6 Pancreatic Cancer
    8.7 Others
9. Alpha-fetoprotein (AFP) Testing Market – By End Use Industry (Market Size -$Million/$Billion)
    9.1 Hospitals 
    9.2 Clinics
    9.3 Others
10. Alpha-fetoprotein (AFP) Testing Market - By Geography (Market Size -$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K.
        10.2.2 Germany
        10.2.3 France
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 Japan
        10.3.3 South Korea
        10.3.4 India
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia-Pacific
    10.4 Rest of the World
        10.4.1 Middle East
        10.4.2 Africa
        10.4.3 South America
11. Alpha-fetoprotein (AFP) Testing Market Entropy
12. Alpha-fetoprotein (AFP) Testing Market- Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Alpha-fetoprotein (AFP) Testing Market - Key Company List by Country Premium Premium
14. Alpha-fetoprotein (AFP) Testing Market Company Analysis
    14.1 Company Revenue, Products, M&A, Developments
    14.2 Company 1
    14.3 Company 2
    14.4 Company 3
    14.5 Company 4
    14.6 Company 5
    14.7 Company 6
    14.8 Company 7
    14.9 Company 8
    14.10 Company 9
    14.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table1 Alpha-fetoprotein (AFP) Testing Market Overview 2019-2024
Table2 Alpha-fetoprotein (AFP) Testing Market Leader Analysis 2018-2019 (US$)
Table3 Alpha-fetoprotein (AFP) Testing MarketProduct Analysis 2018-2019 (US$)
Table4 Alpha-fetoprotein (AFP) Testing MarketEnd User Analysis 2018-2019 (US$)
Table5 Alpha-fetoprotein (AFP) Testing MarketPatent Analysis 2013-2018* (US$)
Table6 Alpha-fetoprotein (AFP) Testing MarketFinancial Analysis 2018-2019 (US$)
Table7 Alpha-fetoprotein (AFP) Testing Market Driver Analysis 2018-2019 (US$)
Table8 Alpha-fetoprotein (AFP) Testing MarketChallenges Analysis 2018-2019 (US$)
Table9 Alpha-fetoprotein (AFP) Testing MarketConstraint Analysis 2018-2019 (US$)
Table10 Alpha-fetoprotein (AFP) Testing Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table11 Alpha-fetoprotein (AFP) Testing Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table12 Alpha-fetoprotein (AFP) Testing Market Threat of Substitutes Analysis 2018-2019 (US$)
Table13 Alpha-fetoprotein (AFP) Testing Market Threat of New Entrants Analysis 2018-2019 (US$)
Table14 Alpha-fetoprotein (AFP) Testing Market Degree of Competition Analysis 2018-2019 (US$)
Table15 Alpha-fetoprotein (AFP) Testing MarketValue Chain Analysis 2018-2019 (US$)
Table16 Alpha-fetoprotein (AFP) Testing MarketPricing Analysis 2019-2024 (US$)
Table17 Alpha-fetoprotein (AFP) Testing MarketOpportunities Analysis 2019-2024 (US$)
Table18 Alpha-fetoprotein (AFP) Testing MarketProduct Life Cycle Analysis 2019-2024 (US$)
Table19 Alpha-fetoprotein (AFP) Testing MarketSupplier Analysis 2018-2019 (US$)
Table20 Alpha-fetoprotein (AFP) Testing MarketDistributor Analysis 2018-2019 (US$)
Table21 Alpha-fetoprotein (AFP) Testing Market Trend Analysis 2018-2019 (US$)
Table22 Alpha-fetoprotein (AFP) Testing Market Size 2018 (US$)
Table23 Alpha-fetoprotein (AFP) Testing Market Forecast Analysis 2019-2024 (US$)
Table24 Alpha-fetoprotein (AFP) Testing Market Sales Forecast Analysis 2019-2024 (Units)
Table25 Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2019-2024 ($)
Table26 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Liver Cancer, 2019-2024 ($)
Table27 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Testes Cancer, 2019-2024 ($)
Table28 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Ovarian Cancer, 2019-2024 ($)
Table29 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Biliary Tract Cancer, 2019-2024 ($)
Table30 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Stomach Cancer, 2019-2024 ($)
Table31 North America Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2019-2024 ($)
Table32 South america Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2019-2024 ($)
Table33 Europe Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2019-2024 ($)
Table34 APAC Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2019-2024 ($)
Table35 Middle East & Africa Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2019-2024 ($)
Table36 Russia Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2019-2024 ($)
Table37 Israel Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2019-2024 ($)
Table38 Top Companies 2018 (US$)Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,
Table39 Product Launch 2018-2019Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,
Table40 Mergers & Acquistions 2018-2019Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,


List of Figures

Figure 1 Overview of Alpha-fetoprotein (AFP) Testing Market 2019-2024
Figure 2 Market Share Analysis for Alpha-fetoprotein (AFP) Testing Market 2018 (US$)
Figure 3 Product Comparison in Alpha-fetoprotein (AFP) Testing Market 2018-2019 (US$)
Figure 4 End User Profile for Alpha-fetoprotein (AFP) Testing Market 2018-2019 (US$)
Figure 5 Patent Application and Grant in Alpha-fetoprotein (AFP) Testing Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Alpha-fetoprotein (AFP) Testing Market 2018-2019 (US$)
Figure 7 Market Entry Strategy in Alpha-fetoprotein (AFP) Testing Market 2018-2019
Figure 8 Ecosystem Analysis in Alpha-fetoprotein (AFP) Testing Market2018
Figure 9 Average Selling Price in Alpha-fetoprotein (AFP) Testing Market 2019-2024
Figure 10 Top Opportunites in Alpha-fetoprotein (AFP) Testing Market 2018-2019
Figure 11 Market Life Cycle Analysis in Alpha-fetoprotein (AFP) Testing Market
Figure 12 GlobalBy Cancer TypeAlpha-fetoprotein (AFP) Testing Market Revenue, 2019-2024 ($)
Figure 13 Global Alpha-fetoprotein (AFP) Testing Market - By Geography
Figure 14 Global Alpha-fetoprotein (AFP) Testing Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15 Global Alpha-fetoprotein (AFP) Testing Market CAGR, By Geography, 2019-2024 (%)
Figure 16 North America Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 17 US Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 18 US GDP and Population, 2018-2019 ($)
Figure 19 US GDP – Composition of 2018, By Sector of Origin
Figure 20 US Export and Import Value & Volume, 2018-2019 ($)
Figure 21 Canada Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 22 Canada GDP and Population, 2018-2019 ($)
Figure 23 Canada GDP – Composition of 2018, By Sector of Origin
Figure 24 Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25 Mexico Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 26 Mexico GDP and Population, 2018-2019 ($)
Figure 27 Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28 Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29 South America Alpha-fetoprotein (AFP) Testing MarketSouth America 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 30 Brazil Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 31 Brazil GDP and Population, 2018-2019 ($)
Figure 32 Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33 Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34 Venezuela Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 35 Venezuela GDP and Population, 2018-2019 ($)
Figure 36 Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37 Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38 Argentina Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 39 Argentina GDP and Population, 2018-2019 ($)
Figure 40 Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41 Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42 Ecuador Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 43 Ecuador GDP and Population, 2018-2019 ($)
Figure 44 Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45 Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46 Peru Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 47 Peru GDP and Population, 2018-2019 ($)
Figure 48 Peru GDP – Composition of 2018, By Sector of Origin
Figure 49 Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50 Colombia Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 51 Colombia GDP and Population, 2018-2019 ($)
Figure 52 Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53 Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54 Costa Rica Alpha-fetoprotein (AFP) Testing MarketCosta Rica 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 55 Costa Rica GDP and Population, 2018-2019 ($)
Figure 56 Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57 Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58 Europe Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 59 U.K Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 60 U.K GDP and Population, 2018-2019 ($)
Figure 61 U.K GDP – Composition of 2018, By Sector of Origin
Figure 62 U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63 Germany Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 64 Germany GDP and Population, 2018-2019 ($)
Figure 65 Germany GDP – Composition of 2018, By Sector of Origin
Figure 66 Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67 Italy Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 68 Italy GDP and Population, 2018-2019 ($)
Figure 69 Italy GDP – Composition of 2018, By Sector of Origin
Figure 70 Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71 France Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 72 France GDP and Population, 2018-2019 ($)
Figure 73 France GDP – Composition of 2018, By Sector of Origin
Figure 74 France Export and Import Value & Volume, 2018-2019 ($)
Figure 75 Netherlands Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 76 Netherlands GDP and Population, 2018-2019 ($)
Figure 77 Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78 Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79 Belgium Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 80 Belgium GDP and Population, 2018-2019 ($)
Figure 81 Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82 Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83 Spain Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 84 Spain GDP and Population, 2018-2019 ($)
Figure 85 Spain GDP – Composition of 2018, By Sector of Origin
Figure 86 Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87 Denmark Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 88 Denmark GDP and Population, 2018-2019 ($)
Figure 89 Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90 Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91 APAC Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 92 China Alpha-fetoprotein (AFP) Testing MarketValue & Volume, 2019-2024
Figure 93 China GDP and Population, 2018-2019 ($)
Figure 94 China GDP – Composition of 2018, By Sector of Origin
Figure 95 China Export and Import Value & Volume, 2018-2019 ($)Alpha-fetoprotein (AFP) Testing MarketChina Export and Import Value & Volume, 2018-2019 ($)
Figure 96 Australia Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 97 Australia GDP and Population, 2018-2019 ($)
Figure 98 Australia GDP – Composition of 2018, By Sector of Origin
Figure 99 Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100 South Korea Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 101 South Korea GDP and Population, 2018-2019 ($)
Figure 102 South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103 South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104 India Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 105 India GDP and Population, 2018-2019 ($)
Figure 106 India GDP – Composition of 2018, By Sector of Origin
Figure 107 India Export and Import Value & Volume, 2018-2019 ($)
Figure 108 Taiwan Alpha-fetoprotein (AFP) Testing MarketTaiwan 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 109 Taiwan GDP and Population, 2018-2019 ($)
Figure 110 Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111 Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112 Malaysia Alpha-fetoprotein (AFP) Testing MarketMalaysia 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 113 Malaysia GDP and Population, 2018-2019 ($)
Figure 114 Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115 Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116 Hong Kong Alpha-fetoprotein (AFP) Testing MarketHong Kong 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 117 Hong Kong GDP and Population, 2018-2019 ($)
Figure 118 Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119 Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120 Middle East & Africa Alpha-fetoprotein (AFP) Testing MarketMiddle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121 Russia Alpha-fetoprotein (AFP) Testing MarketRussia 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122 Russia GDP and Population, 2018-2019 ($)
Figure 123 Russia GDP – Composition of 2018, By Sector of Origin
Figure 124 Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125 Israel Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2019-2024 ($)
Figure 126 Israel GDP and Population, 2018-2019 ($)
Figure 127 Israel GDP – Composition of 2018, By Sector of Origin
Figure 128 Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129 Entropy Share, By Strategies, 2018-2019* (%)Alpha-fetoprotein (AFP) Testing Market
Figure 130 Developments, 2018-2019*Alpha-fetoprotein (AFP) Testing Market
Figure 131 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 132 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 134 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 135 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 137 Company 3Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 138 Company 3Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139 Company 3Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 140 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 141 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 143 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 144 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 146 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 147 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 149 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 150 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 152 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 153 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 155 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 156 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 158 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 159 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 161 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 162 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 164 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 165 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 167 Company 13Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 168 Company 13Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169 Company 13Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 170 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 171 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)
Figure 173 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2018-2019* ($)
Figure 174 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2018 (%)